医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SEASUN BIOMATERIALS Supplies On-site COVID-19 Rapid Molecular Diagnostic System to Seoul National University Campus

2021年05月04日 PM10:00
このエントリーをはてなブックマークに追加


 

DAEJEON, South Korea

SEASUN BIOMATERIALS (CEO: Park Heekyung), a molecular diagnostic company has made its molecular diagnostic system ‘4S’ (SEASUNBIO SMART SHIELD SYSTEM) available at the Seoul National University (SNU) campus after the launching at Incheon International Airport.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210504005599/en/

SEASUN BIOMATERIALS' 4S system, a one-stop COVID-19 molecular diagnostic system located on the Seoul National University campus. (Photo: Business Wire)

SEASUN BIOMATERIALS’ 4S system, a one-stop COVID-19 molecular diagnostic system located on the Seoul National University campus. (Photo: Business Wire)

The 4S on-site diagnostic system is a mobile molecular-laboratory equipped with negative pressure rooms and self-powered equipment for molecular diagnostics intended for rapid molecular examination and prevention of infectious diseases such as COVID-19. The entire procedure of COVID-19 diagnostics takes less than 1 hour which consists of filling out a brief questionnaire, sample collection, nucleic acid extraction, molecular detection and sending report results to customers’ mobile phones.

Since January 2021, SEASUN BIOMATERIALS’ AQ-TOP Plus has been used for COVID-19 detection in the ‘COVID-19 Test Center’ established at Incheon International Airport (ICN). The test results are reported within 2 hours at ICN. The passengers and ICN staff are very satisfied with the rapid and accurate procedure of the AQ-TOP Plus.

SEASUN BIOMATERIALS has two (2) diagnostic platforms of COVID-19 diagnostics, U-TOP COVID-19 and AQ-TOP COVID-19 Series. U-TOP COVID-19 Series is intended for the detailed examination which simultaneously discriminates S gene mutations in addition to the parallel examination of four (4) SARS-CoV-2 genes. AQ-TOP COVID-19 Series is intended for a rapid point-of-care test which is optimized for field diagnostics that requires high accuracy within a short testing time.

All COVID-19 related products of SEASUN BIOMATERIALS used in the 4S system have been officially approved by the MFDS, certified ‘Brand K’, CE-IVD marking and authorized under EUA from the US FDA, and have been exported globally since the first wave of the pandemic.

For more information, please visit www.seasunbio.com and https://youtu.be/QP6Tu9vy8Xk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005599/en/

CONTACT

SEASUN BIOMATERIALS

Sunny, KIM

seasunbio@seasunbio.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 亚马逊与美国国家安全委员会携手开展业界首创合作项目,以解决美国常见的工伤问题
  • Aragen Announce Multi-Year Partnership With FMC Corporation, Aims at Accelerating Agro-Chemical Pipeline
  • 片肺換気中の高酸素血症介在疾患の罹患率にORiを指針とする酸素需要評価が及ぼす影響についての新研究
  • セルトリオン、抗COVID-19モノクローナル抗体治療剤「Regdanvimab(CT-P59)」の グローバル第3相臨床試験結果を発表
  • 沃特世推出SELECT SERIES MRT多反射飞行时间质谱平台,树立高分辨质谱性能新标杆